Table 3.
Management of GPA with end-stage renal disease.
| Survey Question | Specialty, N | Yes, % | No, % | Unsure, % | p-value |
|---|---|---|---|---|---|
| Aside from routine considerations of modality, do you PREFER Hemodialysis over Peritoneal Dialysis (PD) because of the risk of infection from immunosuppression on PD? | Rheum, 55 | 9.1 | 14.5 | 76.4 | P=0.019 |
| Neph, 63 | 17.4 | 74.6 | 7.94 | ||
|
| |||||
| Once a patient is on dialysis, do you try to taper off the immunosuppression earlier than a non-dialysis GPA patient? | Rheum, 55 | 5.5 | 36.4 | 58.2 | <0.0001 |
| Neph, 60 | 28.3 | 70.0 | 1.7 | ||
|
| |||||
| Do you wait for ANCA titer to become negative before listing for transplant? | Rheum, 55 | 3.6 | 16.4 | 80.0 | <0.0001 |
| Neph, 59 | 30.5 | 55.9 | 13.6 | ||
|
| |||||
| Do you believe ANCA titer positivity AT THE TIME OF RENAL TRANSPLANT influences graft survival or vasculitis relapse rate? | Rheum, 55 | 7.3 | 9.1 | 83.6 | <0.0001 |
| Neph, 58 | 25.8 | 51.7 | 22.4 | ||
|
| |||||
| Is your renal transplant INDUCTION immunosuppression for a patient with GPA any different than a non-GPA renal transplant patient? | Rheum, 54 | 3.7 | 3.7 | 92.6 | <0.0001 |
| Neph, 59 | 18.6 | 64.4 | 17.0 | ||
|
| |||||
| Is your renal transplant MAINTENANCE immunosuppression for a patient with GPA any different than a non-GPA renal transplant patient? | Rheum, 55 | 3.6 | 3.6 | 92.7 | <0.0001 |
| Neph, 59 | 20.3 | 66.1 | 13.6 | ||